For the quarter ended December 2024, Inogen (INGN) reported revenue of $80.08 million, up 5.5% over the same period last year. EPS came in at -$0.41, compared to -$1.14 in the year-ago quarter.

The reported revenue represents a surprise of +0.73% over the Zacks Consensus Estimate of $79.5 million. With the consensus EPS estimate being -$0.57, the EPS surprise was +28.07%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Inogen performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenue- Sales revenue: $66.31 million compared to the $60.33 million average estimate based on two analysts. The reported number represents a change of +11.6% year over year.
• Revenue- Rental revenue: $13.77 million compared to the $13.63 million average estimate based on two analysts. The reported number represents a change of -16.5% year over year.
• Gross profit- Rental revenue: $5.48 million compared to the $5.49 million average estimate based on two analysts.
• Gross profit- Sales revenue: $30.81 million versus the two-analyst average estimate of $26.37 million.

View all Key Company Metrics for Inogen here>>>

Shares of Inogen have returned -22.3% over the past month versus the Zacks S&P 500 composite's -7.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Inogen, Inc (INGN) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research